Ensuring balance in national policies on controlled substances

Guidance for availability and accessibility of controlled medicines

REFERENCE LIST 1. WHO Expert Committee on Drug Dependence: sixteenth report. Geneva, World Health Organization, 1969 (Technical report series 407) (http://whqlibdoc.who.int/trs/WHO_TRS_407.pdf; accessed 4 January 2011). 2. WHO lexicon on alcohol and drug terms. (http://www.who.int/substance_abuse/terminology/who_ladt/en/index.html (accessed 4 January 2011). 3. . Convention on the Rights of the Child; 1989 (http://www.unicef.org/crc/files/Definitions.pdf; accessed 4 January 2011). 4. United Nations. Vienna Convention on the Law of Treaties. 1969 [Article 2: Use of Terms] (http://untreaty.un.org/ilc/texts/instruments/english/conventions/1_1_1969.pdf; accessed 4 January 2011). 5. World Health Organization Collaborating Centre for Drugs Statistics Methodology. Guidelines for ATC classification and DDD assignment 2010. Oslo, 2009 (http://www.whocc.no/filearchive/publications/2010guidelines.pdf; accessed 4 January 2011). 6. WHO Expert Committee on Drug Dependence: twenty‐eighth report. Geneva, World Health Organization, 1993 (Technical Report series 836) (http://whqlibdoc.who.int/trs/WHO_TRS_836.pdf; accessed 4 January 2011). 7. World Health Organization. The ICD‐10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. Geneva, 1992 (http://www.who.int/classifications/icd/en/bluebook.pdf; accessed 4 January 2011). 8. World Health Organization, United Nations Office on Drugs and Crime, United Nations Programme on HIV/AIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper. Geneva, 2004 (http://www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf; accessed 4 January 2011). 9. United Nations. Competent national authorities under the international drug control treaties 2008. Vienna, 2009 (https://unp.un.org/Details.aspx?pid=19133; accessed 11 January 2011). 10. Collins Language, ed. Collins English Dictionary. 3rd updated ed. Glasgow; 1994 [Definition of "preamble"]. 11. United Nations. Single Convention on Narcotic Drugs, 1961, as amended by the 1972 Protocol. (http://www.incb.org/pdf/e/conv/convention_1961_en.pdf; accessed 4 January 2011). 12. International Narcotics Control Board. Narcotic drugs: estimated world requirements for 2010; statistics for 2008. New York, United Nations, 2010 (E/INCB/2009/2).

1 13. International Narcotics Control Board. Psychotropic substances: statistics for 2008; assessments of annual medical and scientific requirements for substances in Schedules II, III and IV of the Convention on Psychotropic Substances of 1971. New York, United Nations, 2010 (E/INCB/2009/3). 14. World Health Organization, United Nations Office on Drugs and Crime, United Nations Programme on HIV/AIDS. A 'step‐by‐step' algorithm for the procurement of controlled substances for drug substitution therapy. Thailand, 2007 (http://www.unodc.org/documents/hiv‐aids/Step‐by‐ Step%20procurement%20subs%20treat.pdf, accessed 4 January 2011). 15. World Health Organization. Model guidelines for the international provision of controlled medicines for emergency medical care. Geneva, 1996 (http://apps.who.int/medicinedocs/pdf/who32e/who32e.pdf, accessed 4 January 2011). 16. Commission on Narcotic Drugs. Resolution 53/4: Promoting adequate availability of internationally controlled licit drugs for medical and scientific purposes while preventing their diversion and abuse. 10th Plenary Meeting. 2010. (http://www.unodc.org/documents/commissions/CND‐Res‐2000‐until‐present/CND53_4e.pdf, accessed 4 January 2011). 17. International Narcotics Control Board. Report of the International Narcotics Control Board for 2006. New York, United Nations, 2007 [Paragraph 650]. (Available from: http://www.incb.org/pdf/e/ar/2006/annual‐report‐2006‐en.pdf, accessed 4 January 2011). 18. Nowak M, Grover A. Letter of 10 December 2008 to the Commission on Narcotic Drugs from UN Special Rapporteurs. 2008. (http://www.hrw.org/ru/news/2008/12/10/un‐human‐rights‐ experts‐call‐upon‐cnd‐support‐harm‐reduction, accessed 4 January 2011). 19. United Nations. Constitution of the World Health Organization. New York, 1946. (http://apps.who.int/gb/bd/PDF/bd47/EN/constitution‐en.pdf, accessed 4 January 2011). 20. United Nations. Signatories of the International Covenant on Economic, Social and Cultural Rights. New York, United Nations Treaty Collection, 2011. (http://treaties.un.org/Pages/ViewDetails.aspx?src=TREATY&mtdsg_no=IV‐ 3&chapter=4&lang=en, accessed 4 January 2011). 21. United Nations. Convention on the Elimination of All Forms of Discrimination Against Women. 1979 [Article 12] (http://www.un.org/womenwatch/daw/cedaw/text/econvention.htm, accessed 4 January 2011). 22. United Nations. International Covenant on Civil and Political Rights. 1966. [Article 6 on the right to life] (http://www2.ohchr.org/english/law/ccpr.htm, accessed 4 January 2011). 23. United Nations. United Nations Millennium Declaration, Resolution 55/2. 2000. (http://www.un.org/millennium/declaration/ares552e.htm, accessed 4 January 2011). 24. World Health Organization. Guidelines for the psychosocially assisted pharmacological treatment of opioid dependence. Geneva, 2009 (http://www.who.int/substance_abuse/publications/Opioid_dependence_guidelines.pdf, accessed 4 January 2011). 25. World Health Organization. Cancer pain relief. Geneva, 1986.

2 26. World Health Organization, UNAIDS. AIDS epidemic update, November 2009. Geneva, 2009 (http://data.unaids.org/pub/Report/2009/JC1700_Epi_Update_2009_en.pdf; accessed 4 January 2011). 27. World Health Organization. World malaria report 2009. Geneva, 2009 [p 27] (http://whqlibdoc.who.int/publications/2009/9789241563901_eng.pdf; accessed 5 January 2011). 28. World Health Organization, Global tuberculosis control: a short update to the 2009 report. Geneva, 2009 (http://whqlibdoc.who.int/publications/2009/9789241598866_eng.pdf; accessed 5 January 2011). 29. World Health Organization. Access to controlled medications programme: improving access to medications under international drug conventions: briefing note. Geneva, February 2009 (http://www.who.int/medicines/areas/quality_safety/ACMP_BrNoteGenrl_EN_Feb09.pdf, accessed 5 January 2011). 30. Foley KM et al. Pain control for people with cancer and AIDS. In: Jamison DT, et al., eds. Disease control priorities in developing countries, 2nd ed. New York, NY, Oxford University Press, 2006 (http://files.dcp2.org/pdf/DCP/DCP52.pdf, accessed, 5 January 2011). 31. World Health Organization. Cancer pain relief and palliative care: report of a WHO expert committee. Geneva, 1990 (Technical Report Series 804) (http://whqlibdoc.who.int/trs/WHO_TRS_804.pdf, accessed 5 January 2011). 32. World Health Organization. Cancer pain relief: with a guide to opioid availability, 2nd ed. Geneva, 1996 (http://whqlibdoc.who.int/publications/9241544821.pdf, accessed 5 January 2011). 33. Antman EM et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation, 2007, 115:1634‐1642. 34. FitzGerald GA. COX‐2 in play at the AHA and the FDA. Trends in Pharmacological Sciences, 2007, 28:303‐307. 35. Krakauer EL et al. Opioid inaccessibility and its human consequences: reports from the field. Journal of Pain and Palliative Care Pharmacotherapy, 2010, 24:239‐243. 36. Mathers BM et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet, 2008, 372:1733‐1745. 37. United Nations Office on Drugs and Crime. World Drug Report 2010. New York, United Nations, 2010. 38. World Health Organization, United Nations. AIDS epidemic update: December 2007. Geneva, 2007 (http://data.unaids.org/pub/EPISlides/2007/2007_epiupdate_en.pdf, accessed 5 January 2011). 39. Oral communication of P. Carrieri (INSERM) on 28 March 2006. 40. Gerra, G et al. Long‐acting opioid‐agonists in the treatment of heroin addiction: why should we call them “substitution”?. Substance Use & Misuse, 2009, 44:663‐671. 41. Mathers BM et al. HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage. Lancet, 2010, 375:1014‐1028.

3 42. World Health Organization, UNICEF, UNFPA, The World Bank. Maternal mortality in 2005: estimates developed by WHO, UNICEF, UNFPA and The World Bank. Geneva, World Health Organization, 2007 (http://www.who.int/whosis/mme_2005.pdf, accessed 5 January 2011). 43. World Health Organization. Emergency and surgical procedures at the first referral health facility. Geneva, 2007 (WHO/ETH/CPR/2007) (http://www.who.int/surgery/publications/MP_flyer‐emergency‐and‐surgical.pdf, accessed 5 January 2011). 44. Commission on Narcotic Drugs. Resolution 50/3: Responding to the threat posed by the abuse and diversion of ketamine. 2007 (E/CN.7/2007/16) (http://www.unodc.org/pdf/resolutions/ga_ecosoc_cnd_2007/resolution‐50‐03.pdf, accessed 5 January 2011). 45. International Narcotics Control Board. Report of the International Narcotics Control Board for 2007. New York, United Nations, 2008 [Paragraph 26] (http://www.incb.org/pdf/annual‐ report/2007/en/annual‐report‐2007.pdf, accessed 5 January 2011). 46. World Health Organization. Expert Committee on Drug Dependence: thirty‐fourth report. Geneva, 2006 (Technical Report Series 942) (http://whqlibdoc.who.int/trs/WHO_TRS_942_eng.pdf, accessed 5 January 2011). 47. World Health Organization. Practical anaesthesia. In: Surgical Care at the District Hospital. Geneva, 2003 (http://www.who.int/surgery/publications/en/SCDH.pdf, accessed 5 January 2011). 48. mhGAP Mental Health Gap Action Programme. Scaling up care for mental, neurological, and substance use disorders. Geneva, World Health Organization, 2008 (http://whqlibdoc.who.int/publications/2008/9789241596206_eng.pdf; accessed 5 January 2011). 49. Noble M et al. Long‐term opioid therapy for chronic non‐cancer pain: a systematic review and meta‐analysis of efficacy and safety. Journal of Pain and Symptom Management, 2008, 35:214-228. 50. Niikura K et al. Neuropathic and chronic pain stimuli downregulate central micro ‐opioid and dopaminergic transmission. Trends in Pharmacol Sciences, 2010, 31:299‐305. 51. International Narcotics Control Board. Report of the International Narcotics Control Board for 1995: availability of opiates for medical needs. Special report prepared pursuant to Economic and Social Council resolutions 1990/31 and 1991/43. New York, United Nations. 1996 (http://www.incb.org/pdf/e/ar/1995/suppl1en.pdf, accessed 5 January 2011). 52. International Narcotics Control Board. Report of the International Narcotics Control Board for 2009. New York, United Nations, 2010 [Paragraph 789] (http://www.incb.org/pdf/annual‐ report/2009/en/AR_09_English.pdf, accessed 5 January 2011). 53. International Narcotics Control Board. Report of the International Narcotics Control Board for 2004. New York, United Nations, 2005. 54. . The International Opium Convention, signed at The Hague, January 23, 1912, and other subsequent relative papers. 1912 (Treaty Series N° 222) (http://www.worldlii.org/int/other/LNTSer/1922/29.html; accessed 5 January 2011).

4 55. International Narcotics Control Board. Report of the International Narcotics Control Board for 1989: demand for and supply of opiates for medical and scientific needs. New York, United Nations, 1989. 56. Joranson DE. Availability of opioids for cancer pain: recent trends, assessment of system barriers, New World Health Organization guidelines, and the risk of diversion. Journal of Pain and Symptom Management, 1993, 8:353‐360. 57. Joranson DE. New international efforts to ensure availability of opioids for medical purposes. Journal of Pain and Symptom Management, 1996, 12:85‐86. 58. International Narcotics Control Board. Report of the International Narcotics Control Board for 1999. New York, United Nations, 1999. (E/INCB/1999/1) [chapter I Freedom from pain and suffering]. 59. United Nations. Convention on Psychotropic Substances. 1971 (http://www.incb.org/pdf/e/conv/convention_1971_en.pdf; accessed 5 January 2011). 60. United Nations Economic and Social Council. General Comment No. 14 (2000): The right to the highest attainable standard of health (article 12 of the International Covenant on Economic, Social and Cultural Rights). Geneva, United Nations, 2000 (E/C.12/2000/4) (http://www.unhchr.ch/tbs/doc.nsf/(Symbol)/40d009901358b0e2c1256915005090be?Opendoc ument; accessed 5 January 2011). 61. United Nations. International Covenant on Economic, Social and Cultural Rights. New York, 1966 (http://www2.ohchr.org/english/law/cescr.htm; accessed 5 January 2011). 62. United Nations. Resolution ECOSOC 2005/25: Treatment of pain using opioid analgesics. 36th plenary meeting, 2005 (http://www.un.org/docs/ecosoc/documents/2005/resolutions/Resolution%202005‐25.pdf; accessed 5 January 2011). 63. World Health Organization. Resolution WHA 58.22: Cancer prevention and control. Geneva, World Health Assembly 58, 2005 (http://www.who.int/ipcs/publications/wha/cancer_resolution.pdf; assessed 5 January 2011). 64. Special Rapporteur on torture and other cruel, inhuman or degrading treatment or punishment. Promotion and protection of all , civil, political, economic, social and cultural rights, including the right to development. United Nations Human Rights Council, 2009 (A/HRC/10/44) (http://www2.ohchr.org/english/bodies/hrcouncil/docs/10session/A.HRC.10.44AEV.pdf; accessed 5 January 2011). 65. African Union. African Charter on the Rights and Welfare of the Child. OAU Doc. CAB/LEG/24.9/49 (1990), entered into force Nov. 29, 1999.( http://www.africa‐ union.org/official_documents/Treaties_%20Conventions_%20Protocols/a.%20C.%20ON%20THE %20RIGHT%20AND%20WELF%20OF%20CHILD.pdf; accessed 6 January 2011). 66. African Commission on Human and Peoples’ Rights. African Charter on Human and Peoples’ Rights. 1979 (http://www.achpr.org/english/_info/charter_en.html; accessed 6 January 2011). 67. Council of Europe. Convention for the Protection of Human Rights and Fundamental Freedoms. 1950 (http://conventions.coe.int/treaty/en/Treaties/Html/005.htm; accessed 6 January 2011).

5 68. Council of Europe. European Social Charter. Turin, 1961 (http://conventions.coe.int/Treaty/en/Treaties/Html/035.htm; accessed 6 January 2011). 69. Organization of American States. Additional Protocol to the American Convention on Human Rights in the area of Economic, Social, and Cultural Rights: “Protocol of San Salvador”. 1988 (http://www.oas.org/juridico/english/treaties/a‐52.html; accessed 6 January 2011). 70. World Health Organization. Palliative care. Geneva, 2007 (Cancer control: knowledge into action: WHO guide for effective programmes, module 5) (http://www.who.int/cancer/media/FINAL‐Palliative%20Care%20Module.pdf; accessed 6 January 2011). 71. World Health Organization. Palliative care: symptom management and end‐of‐life care: integrated management of adolescent and adult illness: interim guidelines for first‐level health facility workers. Geneva, 2004 (http://www.who.int/hiv/pub/imai/primary_palliative/en/index.html; accessed 6 January 2011). 72. World Health Organization. Effectiveness of drug dependence treatment in preventing HIV among injecting drug users. Geneva, 2005 (Evidence for action technical paper) (http://www.who.int/hiv/pub/idu/drugdependence_final.pdf; accessed 6 January 2011). 73. World Health Organization, United Nations Programme on HIV/AIDS, United Nations Office on Drugs and Crime. Evidence for action on HIV/AIDS and injecting drug use. policy brief: reduction of HIV transmission through drug‐dependence treatment. Geneva, 2004 (http://whqlibdoc.who.int/hq/2004/WHO_HIV_2004.04.pdf; accessed 6 January 2011). 74. World Health Organization, United Nations Office on Drugs and Crime, UNAIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper. Geneva; 2004 (http://www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf; accessed 6 January 2011). 75. World Health Organization. WHO recommendations for the prevention of postpartum haemorrhage. Geneva, 2007 (http://www.who.int/making_pregnancy_safer/publications/WHORecommendationsforPPHae morrhage.pdf; accessed 6 January 2011). 76. World Health Organization. Guidelines for the management of postpartum haemorrhage and retained placenta. Geneva, 2009 (http://whqlibdoc.who.int/publications/2009/9789241598514_eng.pdf; accessed 6 January 2011). 77. World Health Organization, UNICEF, UNFPA, The World Bank. Managing complications in pregnancy and childbirth: a guide for midwives and doctors. Geneva, 2000 (reprint 2007) (Integrated Management of Pregnancy and Childbirth) (http://whqlibdoc.who.int/publications/2007/9241545879_eng.pdf; accessed 6 January 2011). 78. World Health Organization, United Nations Office on Drugs and Crime, UNAIDS. Substitution maintenance therapy in the management of opioid dependence and HIV/AIDS prevention: position paper. Geneva, 2004. (http://www.who.int/substance_abuse/publications/en/PositionPaper_English.pdf; accessed 6 January 2011).

6 79. Open Society Institute. Harm reduction developments 2008: countries with injection‐driven HIV epidemics. New York, 2008 (http://www.ahrn.net/library_upload/uploadfile/file3138.pdf; accessed 6 January 2011). 80. United Nations. Convention against Torture and Other Cruel, Inhuman or Degrading Treatment or Punishment. New York, General Assembly, 1984 (http://www2.ohchr.org/english/law/pdf/cat.pdf; accessed 6 January 2011). 81. Eramova I, Matic S, Munz M, eds. HIV/AIDS treatment and care: clinical protocols for the WHO European Region. Copenhagen, World Health Organization, 2007 [See chapter 5: HIV/AIDS treatment and care for injecting drug users: clinical protocol for the WHO European Region] (http://www.euro.who.int/__data/assets/pdf_file/0004/78106/E90840.pdf). 82. Pinkham S, Malinowska‐Sempruch K. Women, harm reduction, and HIV. New York, International Harm Reduction Development Program of the Open Society Institute, 2007 (http://www.soros.org/initiatives/health/focus/ihrd/articles_publications/publications/women_ 20070920/women_20070920.pdf; accessed 6 January 2011). 83. United Nations. The Universal Declaration of Human Rights. New York, 1948 (http://www.un.org/en/documents/udhr/index.shtml; accessed 6 January 2011). 84. De Lima L et al. Legislation analysis according to WHO and INCB criteria on opioid availability: a comparative study of 5 countries and the state of Texas. Health Policy, 2001, 56:99‐110. 85. Zenz M, Willweber‐Strumpf A. Opiophobia and cancer pain in Europe. Lancet, 1993, 341:1075‐1076. 86. Torres‐Vigil I et al. Health care providers' assessments of the quality of advanced‐cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and Peru. Journal of Pain & Palliative Care Pharmacotherapy, 2008, 22:7‐ 20. 87. Lynch T et al. Barriers to the development of palliative care in the countries of central and eastern Europe and the Commonwealth of Independent States. Journal of Pain and Symptom Management, 2009; 37:305‐315. 88. Leon MX et al., Improving availability of and access to opioids in Colombia: description and preliminary results of an action plan for the country. Journal of Pain & Symptom Management, 2009, 38:758‐766. 89. Cherny NI et al. Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in Europe: a report from the ESMO/EAPC Opioid Policy Initiative. Annals of Oncology, 2010, 21:615‐626. 90. Commission on Narcotic Drugs. Resolution CND 1983/2: Application of estimate system to substances in Schedule II of the Convention on Psychotropic Substances. 1983 (https://www.unodc.org/documents/commissions/CND‐Res‐1980to1989/CND‐1983‐ Session30_XXX/CND‐Resolution‐30‐02.pdf; accessed 6 January 2011). 91. Commission on Narcotic Drugs. Resolution CND 39/7: Timely provision of controlled drugs for emergency care. Vienna, United Nations Office on Drugs and Crime, 1996 (http://www.unodc.org/documents/commissions/CND‐Res‐1990to1999/CND‐1996‐ Session39/CND‐Resolution‐39‐07.pdf; accessed 4 January 2011).

7 92. World Health Organizaton. Resolution WHA 49.18: Collaboration within the United Nations system and with other international organizatons: supply of controlled drugs for emergency care. Geneva, World Health Assembly 49, 25 May 1996 (http://apps.who.int/medicinedocs/fr/d/Jwho32e/10.html; accessed 4 January 2011). 93. Hellerstein DJ, Biedermann GB. Physician concerns with United States Drug Enforcement Agency Schedule II central nervous system stimulants. Primary Psychiatry, 2003, 10:47‐52. 94. Jaffe JH. Impact of scheduling on the practice of medicine and biomedical research. Drug and Alcohol Dependence, 1985, 14:403‐418. 95. World Health Organization. WHO model list of essential medicines (adults), 16th ed. Geneva, 2010 (http://www.who.int/medicines/publications/essentialmedicines/en/). 96. World Health Organization. WHO model list of essential medicines (children), 2nd ed. (updated). Geneva, 2010 (http://www.who.int/medicines/publications/essentialmedicines/en/).

8